← Back to Search

Anti-epileptic drug

Topiramate and N-Acetyl Cysteine for Alcoholism

Phase < 1
Waitlist Available
Led By Nassima Ait-Daoud Tiouririne, M.D.
Research Sponsored by Nassima Ait-Daoud Tiouririne
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up drinc is at screen, weeks 1,5,9, and 13
Awards & highlights

Study Summary

This is a pilot study designed to evaluate the safety, tolerability of Topiramate (TPM) + N-Acetyl Cysteine (NAC) in combination versus Topiramate (TPM) + placebo for the treatment of alcohol use disorder (AUD).

Eligible Conditions
  • Alcoholism

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~drinc is at screen, weeks 1,5,9, and 13
This trial's timeline: 3 weeks for screening, Varies for treatment, and drinc is at screen, weeks 1,5,9, and 13 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cognitive side effects
Secondary outcome measures
Clinical Global Improvement (CGI) scale
Drinking Inventory of Consequence (DrInC) scale
Drinks per Drinking Day
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Topiramate and PlaceboExperimental Treatment1 Intervention
Drug: Topiramate and Placebo Other Name for Topiramate: Topamax Other Name for Placebo: Sugar Pill
Group II: Topiramate and N-Acetyl CysteineExperimental Treatment1 Intervention
Drug: Topiramate and N-Acetyl Cysteine Other Name for Topiramate: Topamax

Find a Location

Who is running the clinical trial?

Nassima Ait-Daoud TiouririneLead Sponsor
2 Previous Clinical Trials
220 Total Patients Enrolled
1 Trials studying Alcoholism
20 Patients Enrolled for Alcoholism
Nassima Ait-Daoud Tiouririne, M.D.Principal InvestigatorUniversity of Virginia
3 Previous Clinical Trials
1,308 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2 spots leftby Apr 2025